Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
PHYSICIAN PERSPECTIVE - Get With the Protocol - NSTEMI Decision-Tree Accelerates Introduction of Evidence-Based Therapies
University of Ottawa Heart Institute
February 2015
Guest Editor: Michel Le May, MD, FRCPCDirector, Coronary Care Unit, and University of Ottawa Heart Institute Regional STEMI ProgramProfessor of MedicineUniversity of Ottawa Heart InstituteOttawa, Ontario Introduction In patients...
PRIORITY PRESS - American Heart Association (AHA) Scientific Sessions 2014
Lower Is Better: New Data Confirm the LDL Hypothesis as New Options Are Identified for Improved Control
Chicago, Illinois / November 15-19, 2014
Chicago - New evidence of a cardiovascular (CV) benefit from lipid-lowering therapy with a non-statin has extended the lipid hypothesis, expanding opportunities for risk reduction. One of the trials presented at the 2014 Scientific Sessions...
PRIORITY PRESS - 11th Canadian Immunization Conference
Influenza in the Elderly: Seeking More Effective Vaccine Strategies
Ottawa, Ontario / December 2-4, 2014
Ottawa - Elderly patients are at high risk for developing influenza and its complications, which can include increased frailty after hospitalization. Immunization in this population is vital, despite the fact that immune senescence lowers...
PRIORITY PRESS - 11th Canadian Immunization Conference
Expanding Protection against Influenza in the Most Vulnerable: Focus on Adjuvanted Influenza Vaccines
Ottawa, Ontario / December 2-4, 2014
Ottawa – The burden of illness associated with influenza infection is considerable, and it is particularly pronounced in the very young and in the elderly. Both groups respond less than optimally to standard influenza vaccines and...
PRIORITY PRESS - 11th Canadian Immunization Conference
Integrating the New Meningococcal B Vaccine into Clinical Practice: Lessons From the Experts
Ottawa, Ontario / December 2-4, 2014
Ottawa – Of the 5 serogroups responsible for invasive meningococcal disease (IMD), serogroup B is by far the most common in Canada today. IMD also disproportionately affects young infants with another peak in incidence in...
PRIORITY PRESS - 56th Annual Meeting of the American Society of Hematology (ASH)
Selecting Second- and Third-Line TKIs in CML: Offering Tolerability in the Context of Indefinite Disease Control
San Francisco, California / December 6-9, 2014
San Francisco - A focus on the relative long-term safety and tolerability of available tyrosine kinase inhibitors (TKIs) for treatment of chronic myeloid leukemia (CML) has been intensified by the evidence that drugs in this class, when...
PRIORITY PRESS - 11th Canadian Immunization Conference
A Primer on HPV Vaccination for Primary Care Practitioners: NACI Recommendations Should Prevail
Ottawa, Ontario / December 2-4, 2014
Ottawa - Primary care providers are required to answer three questions for patients when they come asking about the human papilloma virus (HPV) vaccine: Is it safe? Does it work? And what do you think about it? Providing good,...
PHYSICIAN PERSPECTIVE - Viewpoint based on presentations from the American Heart Association (AHA) 2014 Scientific Sessions
IMPROVE-IT: Reaffirmation of Lipid Hypothesis By Non-Statin Ezetimibe in High-Risk Population
Chicago, Illinois / November 15-19, 2014
Guest Editor: Dr. Paul W. Armstrong, MD, FCAHS, FRSCDistinguished University ProfessorMazankowski Alberta Heart InstituteUniversity of AlbertaEdmonton, Alberta Dr. Armstrong served on the Steering Committee of IMPROVE-IT and was one of...
PRIORITY PRESS - Canadian Cardiovascular Congress (CCC)
The LDL-C Treatment Gap Expected to Be Essentially Closed with New Lipid-Lowering Agents
Vancouver, BC / October 25-28, 2014
Vancouver - Lipid-lowering therapies now in late stages of development are expected to bring the majority of patients to guideline-recommended treatment goals regardless of the reason why they are unable to reach their goal on current...